Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Richard W. Edelman sold 16,000 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $34.46, for a total transaction of $551,360.00. Following the transaction, the director now owns 17,621 shares of the company’s stock, valued at $607,219.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) traded up 1.31% during midday trading on Friday, hitting $34.75. 153,215 shares of the company traded hands. The company has a 50-day moving average price of $31.85 and a 200-day moving average price of $28.08. The stock has a market capitalization of $1.73 billion, a P/E ratio of 51.63 and a beta of 0.93. Merit Medical Systems, Inc. has a 52 week low of $18.22 and a 52 week high of $34.80.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, April 27th. The medical instruments supplier reported $0.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.23 by $0.05. Merit Medical Systems had a net margin of 3.25% and a return on equity of 8.85%. The business had revenue of $171.07 million for the quarter, compared to analyst estimates of $163.50 million. During the same quarter in the prior year, the business posted $0.19 EPS. Merit Medical Systems’s revenue for the quarter was up 23.9% compared to the same quarter last year. Analysts anticipate that Merit Medical Systems, Inc. will post $1.17 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

ILLEGAL ACTIVITY WARNING: “Insider Selling: Merit Medical Systems, Inc. (MMSI) Director Sells 16,000 Shares of Stock” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/05/26/insider-selling-merit-medical-systems-inc-mmsi-director-sells-16000-shares-of-stock.html.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. bought a new position in shares of Merit Medical Systems during the first quarter worth about $102,000. SG Americas Securities LLC bought a new position in shares of Merit Medical Systems during the first quarter worth about $134,000. State of Alaska Department of Revenue raised its position in shares of Merit Medical Systems by 13.1% in the first quarter. State of Alaska Department of Revenue now owns 5,430 shares of the medical instruments supplier’s stock worth $156,000 after buying an additional 630 shares during the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in shares of Merit Medical Systems by 2,513.6% in the first quarter. Cornerstone Capital Management Holdings LLC. now owns 6,900 shares of the medical instruments supplier’s stock worth $199,000 after buying an additional 6,636 shares during the last quarter. Finally, Suntrust Banks Inc. bought a new position in shares of Merit Medical Systems during the first quarter worth about $214,000. Institutional investors and hedge funds own 91.92% of the company’s stock.

MMSI has been the subject of several recent research reports. Canaccord Genuity reiterated a “buy” rating and set a $35.00 target price on shares of Merit Medical Systems in a report on Monday, February 27th. Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “strong-buy” rating and set a $34.00 target price for the company in a report on Friday, February 24th. Piper Jaffray Companies reiterated an “overweight” rating on shares of Merit Medical Systems in a report on Wednesday, March 29th. Craig Hallum initiated coverage on shares of Merit Medical Systems in a report on Monday, April 17th. They set a “buy” rating and a $36.00 target price for the company. Finally, Sidoti reiterated a “buy” rating and set a $41.00 target price (up from $35.00) on shares of Merit Medical Systems in a report on Saturday, April 29th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $33.28.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

12 Month Chart for NASDAQ:MMSI

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.